When the tumor necrosis factor–related apoptosis-inducing ligand receptor 2 and 4-1BB receptor were co-expressed on CAR T cells, the CAR T cell responses against tumor-associated mucin 1 or HER2 on breast cancer were improved. This evidence concerns the gene ERBB2 and breast carcinoma.